Clinical Trial

AMBulatory UltraSound for Heart Failure Management

Study acronym: AMBUSH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 17, 2023 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
AMBUSH study is a multicenter randomized, controlled, open-label clinical trial (PROBE (Prospective Randomized Open Blinded End-point) type). The main objective of AMBUSH study is to assess the effect of therapeutic management guided by pulmonary ultrasound and the assessment of the inferior vena cava in patients with heart failure seen in an ambulatory (outpatient) setting on a mixed clinical-biological endpoint (including variations of natriuretic peptides - NtProBNP) at 30 days.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-02-04; most recent amendment 2023-05-15.
Status change: Not Yet Recruiting → Recruiting 2023-05-15
Trial Details
NCT Number NCT04741711
Lead Sponsor Central Hospital, Nancy, France
Conditions Heart Failure
Enrollment 182 participants
Start Date 2023-05-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2023-05-17